SARS-CoV-2 – scientific resources

Share on linkedin
Share on twitter
Share on facebook
Some interesting scientific resources on SARS-CoV-2

1. Investigational anti-SARS-CoV-2 molecules show efficacy in pre-clinical studies
“Pre-clinical testing of the COVIDTRAP™ (STI-4398) protein and STI-1499 antibody reveal they can inhibit SARS-CoV-2 from infecting cells”…to read the full article click here

2. The Evolution of the COVID-19 vaccine development landscape
Authors: Tung Thanh Le, Jakob P. Cramer, Robert Chen & Stephen Mayhew
“The COVID-19 vaccine R&D landscape has developed at unprecedented scale and speed since our initial analysis in April identified 115 candidates in the pipeline (Nat. Rev. Drug Discov19, 305–306; 2020). In this updated overview, we focus on candidates in clinical trials and provide some initial perspectives on their clinical development”…to read the full article click here

Evidentic as company can provide you therapeutic antibodies during the early development stage. Some popular choices from our list of therapeutic antibodies are:

Avelumab – Drug Aliquots

Bevacizumab – Drug Aliquots

Cetuximab – Drug Aliquots

See the full list of therapeutic antibodies and get them delivered in less than 7 days.

Publishing Date:
Friday, 18 September, 2020

Categories

About Evidentic

Evidentic is a young innovative company providing original drugs for research and new drug development.
Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.

Follow Us

Introduction to Evidentic

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Facebook

By loading the post, you agree to Facebook's privacy policy.
Learn more

Load post

Read more

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.